{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:44:42Z","timestamp":1794487482960,"version":"4.9.1"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Rev. Neurosci."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41583-023-00776-9","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T14:02:50Z","timestamp":1704722570000},"page":"91-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":216,"title":["Cell type-specific roles of APOE4 in Alzheimer disease"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-6901","authenticated-orcid":false,"given":"Jessica","family":"Blumenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-7167","authenticated-orcid":false,"given":"Oscar","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0115","authenticated-orcid":false,"given":"Min Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4589","authenticated-orcid":false,"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204\u20131222 (2012).","journal-title":"Cell"},{"key":"776_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"776_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 280\u2013292 (2011).","journal-title":"Alzheimers Dement."},{"key":"776_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 270\u2013279 (2011).","journal-title":"Alzheimers Dement."},{"key":"776_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt, L. et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 15, 888\u2013898 (2019).","journal-title":"Alzheimers Dement."},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson, A. et al. Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement. 19, 658\u2013670 (2023).","journal-title":"Alzheimers Dement."},{"key":"776_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375, 754\u2013760 (1995).","journal-title":"Nature"},{"key":"776_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349, 704\u2013706 (1991).","journal-title":"Nature"},{"key":"776_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180\u2013184 (1994).","journal-title":"Nat. Genet."},{"key":"776_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"776_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley, R. W. & Rall, S. C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genom. Hum. Genet. 1, 507\u2013537 (2000).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"776_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber, K. H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249\u2013302 (1994).","journal-title":"Adv. Protein Chem."},{"key":"776_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang, Y. & Mahley, R. W. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol. Dis. 72, 3\u201312 (2014).","journal-title":"Neurobiol. Dis."},{"key":"776_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"776_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903\u2013907 (2011).","journal-title":"Mol. Psychiatry"},{"key":"776_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-201606","volume":"81","author":"Y-Y Wang","year":"2021","unstructured":"Wang, Y.-Y. et al. The proportion of APOE4 carriers among non-demented individuals: a pooled analysis of 389,000 community-dwellers. J. Alzheimers Dis. 81, 1331\u20131339 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"776_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000334607","volume":"38","author":"A Ward","year":"2012","unstructured":"Ward, A. et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 38, 1\u201317 (2012).","journal-title":"Neuroepidemiology"},{"key":"776_CR18","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1074\/jbc.R800009200","volume":"284","author":"N Zhong","year":"2009","unstructured":"Zhong, N. & Weisgraber, K. H. Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure. J. Biol. Chem. 284, 6027\u20136031 (2009).","journal-title":"J. Biol. Chem."},{"key":"776_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"776_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris, N., Nelson, M. R., Rao, A. & Huang, Y. Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms. Annu. Rev. Pathol. Mech. Dis. 17, 73\u201399 (2022).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"776_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens, Y. A. et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110, 1304\u20131317 (2022).","journal-title":"Neuron"},{"key":"776_CR22","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang, Y. et al. Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl Acad. Sci. USA 98, 8838\u20138843 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"776_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N. et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat. Aging 3, 275\u2013296 (2023).","journal-title":"Nat. Aging"},{"key":"776_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68\u201380 (2021).","journal-title":"Lancet Neurol."},{"key":"776_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/cimb43010018","volume":"43","author":"J Iannucci","year":"2021","unstructured":"Iannucci, J., Sen, A. & Grammas, P. Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells in vitro. Curr. Issues Mol. Biol. 43, 215\u2013225 (2021).","journal-title":"Curr. Issues Mol. Biol."},{"key":"776_CR27","doi-asserted-by":"publisher","unstructured":"Haney, M. S. et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s microglia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.07.21.549930 (2023).","DOI":"10.1101\/2023.07.21.549930"},{"key":"776_CR28","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson, M. R. et al. The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration and neuroinflammation. Nat. Neurosci. 26, 2104\u20132121 (2023).","journal-title":"Nat. Neurosci."},{"key":"776_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194\u2013208 (2020).","journal-title":"Nat. Neurosci."},{"key":"776_CR30","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar, S. & Holtzman, D. M. APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin. Immunol. 59, 101594 (2022).","journal-title":"Semin. Immunol."},{"key":"776_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard, J. W. et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611, 769\u2013779 (2022).","journal-title":"Nature"},{"key":"776_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nlac054","volume":"81","author":"GW-Y Cheng","year":"2022","unstructured":"Cheng, G. W.-Y. et al. Apolipoprotein E \u03b54 mediates myelin breakdown by targeting oligodendrocytes in sporadic Alzheimer disease. J. Neuropathol. Exp. Neurol. 81, 717\u2013730 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"776_CR33","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron 109, 2413\u20132426.e7 (2021).","journal-title":"Neuron"},{"key":"776_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221137","volume":"219","author":"G Barisano","year":"2022","unstructured":"Barisano, G. et al. A \u2018multi-omics\u2019 analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice. J. Exp. Med. 219, e20221137 (2022).","journal-title":"J. Exp. Med."},{"key":"776_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne, A. et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581, 71\u201376 (2020).","journal-title":"Nature"},{"key":"776_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","volume":"1","author":"A Montagne","year":"2021","unstructured":"Montagne, A. et al. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-\u03b2. Nat. Aging 1, 506\u2013520 (2021).","journal-title":"Nat. Aging"},{"key":"776_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin, A.-C. et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 17, 72 (2022).","journal-title":"Mol. Neurodegener."},{"key":"776_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501\u2013518 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"776_CR39","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu, Q. et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985\u20134994 (2006).","journal-title":"J. Neurosci."},{"key":"776_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D. & Mahley, R. W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148\u2013161 (1987).","journal-title":"Biochim. Biophys. Acta"},{"key":"776_CR41","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI112130","volume":"76","author":"JK Boyles","year":"1985","unstructured":"Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W. & Taylor, J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501\u20131513 (1985).","journal-title":"J. Clin. Invest."},{"key":"776_CR42","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1523\/JNEUROSCI.2281-14.2014","volume":"34","author":"J Knoferle","year":"2014","unstructured":"Knoferle, J. et al. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice. J. Neurosci. 34, 14069\u201314078 (2014).","journal-title":"J. Neurosci."},{"key":"776_CR43","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657\u20131674.e7 (2021).","journal-title":"Neuron"},{"key":"776_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-023-00610-x","volume":"18","author":"M Xiong","year":"2023","unstructured":"Xiong, M. et al. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy. Mol. Neurodegener. 18, 17 (2023).","journal-title":"Mol. Neurodegener."},{"key":"776_CR45","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1038\/s41380-020-00956-4","volume":"26","author":"Y Xia","year":"2021","unstructured":"Xia, Y. et al. C\/EBP\u03b2 is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer\u2019s disease. Mol. Psychiatry 26, 6002\u20136022 (2021).","journal-title":"Mol. Psychiatry"},{"key":"776_CR46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85779","volume":"12","author":"ME Wynne","year":"2023","unstructured":"Wynne, M. E. et al. APOE expression and secretion are modulated by mitochondrial dysfunction. eLife 12, e85779 (2023).","journal-title":"eLife"},{"key":"776_CR47","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco, M. F., Sepulveda, J., Kopetsky, G. & Rebeck, G. W. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 69, 1478\u20131493 (2021).","journal-title":"Glia"},{"key":"776_CR48","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1074\/jbc.M309475200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris, F. M. et al. Astroglial regulation of apolipoprotein E expression in neuronal cells: implications for Alzheimer\u2019s disease. J. Biol. Chem. 279, 3862\u20133868 (2004).","journal-title":"J. Biol. Chem."},{"key":"776_CR49","doi-asserted-by":"publisher","first-page":"100350","DOI":"10.1016\/j.jlr.2023.100350","volume":"64","author":"AG Cashikar","year":"2023","unstructured":"Cashikar, A. G. et al. Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol. J. Lipid Res. 64, 100350 (2023).","journal-title":"J. Lipid Res."},{"key":"776_CR50","doi-asserted-by":"publisher","first-page":"175909142211445","DOI":"10.1177\/17590914221144549","volume":"15","author":"I Mhatre-Winters","year":"2023","unstructured":"Mhatre-Winters, I., Eid, A., Han, Y., Tieu, K. & Richardson, J. R. Sex and APOE genotype alter the basal and induced inflammatory states of primary astrocytes from humanized targeted replacement mice. ASN Neuro 15, 17590914221144549 (2023).","journal-title":"ASN Neuro"},{"key":"776_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.stemcr.2021.11.007","volume":"17","author":"SM de Leeuw","year":"2022","unstructured":"de Leeuw, S. M. et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes. Stem Cell Rep. 17, 110\u2013126 (2022).","journal-title":"Stem Cell Rep."},{"key":"776_CR52","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1073\/pnas.1609896113","volume":"113","author":"W-S Chung","year":"2016","unstructured":"Chung, W.-S. et al. Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes. Proc. Natl Acad. Sci. USA 113, 10186\u201310191 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2019.00014","volume":"11","author":"CG Fernandez","year":"2019","unstructured":"Fernandez, C. G., Hamby, M. E., McReynolds, M. L. & Ray, W. J. The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease. Front. Aging Neurosci. 11, 14 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"776_CR54","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin, Y.-T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154.e7 (2018).","journal-title":"Neuron"},{"key":"776_CR55","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3390\/antiox11112168","volume":"11","author":"E Staurenghi","year":"2022","unstructured":"Staurenghi, E. et al. ApoE3 vs. ApoE4 astrocytes: a detailed analysis provides new insights into differences in cholesterol homeostasis. Antioxidants 11, 2168 (2022).","journal-title":"Antioxidants"},{"key":"776_CR56","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum. Mol. Genet. 26, 2690\u20132700 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"776_CR57","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji, K., Hosono, T., Nakamura, T., Bu, G. & Michikawa, M. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J. Biol. Chem. 286, 17536\u201317542 (2011).","journal-title":"J. Biol. Chem."},{"key":"776_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512\u2013516 (2012).","journal-title":"Nature"},{"key":"776_CR59","doi-asserted-by":"publisher","first-page":"111200","DOI":"10.1016\/j.celrep.2022.111200","volume":"40","author":"L Arnaud","year":"2022","unstructured":"Arnaud, L. et al. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation. Cell Rep. 40, 111200 (2022).","journal-title":"Cell Rep."},{"key":"776_CR60","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw, J. et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213\u20132233.e25 (2022).","journal-title":"Cell"},{"key":"776_CR61","doi-asserted-by":"publisher","unstructured":"Windham, I. A. et al. APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.04.28.538740 (2023).","DOI":"10.1101\/2023.04.28.538740"},{"key":"776_CR62","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41593-023-01288-6","volume":"26","author":"Z-P Chen","year":"2023","unstructured":"Chen, Z.-P. et al. Lipid-accumulated reactive astrocytes promote disease progression in epilepsy. Nat. Neurosci. 26, 542\u2013554 (2023).","journal-title":"Nat. Neurosci."},{"key":"776_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01631-0","volume":"11","author":"W Fang","year":"2021","unstructured":"Fang, W. et al. APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline. Transl. Psychiatry 11, 507 (2021).","journal-title":"Transl. Psychiatry"},{"key":"776_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","volume":"16","author":"BC Farmer","year":"2021","unstructured":"Farmer, B. C. et al. APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Mol. Neurodegener. 16, 62 (2021).","journal-title":"Mol. Neurodegener."},{"key":"776_CR65","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.nbd.2020.104742","volume":"136","author":"HC Williams","year":"2020","unstructured":"Williams, H. C. et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiol. Dis. 136, 104742 (2020).","journal-title":"Neurobiol. Dis."},{"key":"776_CR66","doi-asserted-by":"publisher","first-page":"113183","DOI":"10.1016\/j.celrep.2023.113183","volume":"42","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep. 42, 113183 (2023).","journal-title":"Cell Rep."},{"key":"776_CR67","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","volume":"109","author":"X Li","year":"2021","unstructured":"Li, X. et al. Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. Neuron 109, 957\u2013970.e8 (2021).","journal-title":"Neuron"},{"key":"776_CR68","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang, S., Zhang, Z., Cao, J., Yu, Y. & Pei, G. Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology. Signal Transduct. Target. Ther. 7, 176 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"776_CR69","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen, Y., Durakoglugil, M. S., Xian, X. & Herz, J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl Acad. Sci. USA 107, 12011\u201312016 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR70","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/brain\/awab478","volume":"145","author":"RJ Jackson","year":"2021","unstructured":"Jackson, R. J. et al. APOE4 derived from astrocytes leads to blood\u2013brain barrier impairment. Brain 145, 3582\u20133593 (2021).","journal-title":"Brain"},{"key":"776_CR71","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch, S. et al. Impaired autophagy in APOE4 astrocytes. J. Alzheimers Dis. 51, 915\u2013927 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"776_CR72","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan, A. M. et al. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 9, 305\u2013318 (2002).","journal-title":"Neurobiol. Dis."},{"key":"776_CR73","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman, D. M. et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 97, 2892\u20132897 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan, T. E. et al. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol. Neurodegener. 17, 13 (2022).","journal-title":"Mol. Neurodegener."},{"key":"776_CR75","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht, W. J. et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527\u20132534 (2004).","journal-title":"J. Neurosci."},{"key":"776_CR76","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","volume":"156","author":"I Tesseur","year":"2000","unstructured":"Tesseur, I. et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156, 951\u2013964 (2000).","journal-title":"Am. J. Pathol."},{"key":"776_CR77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108870119","volume":"119","author":"SR Saroja","year":"2022","unstructured":"Saroja, S. R., Gorbachev, K., Tcw, J., Goate, A. M. & Pereira, A. C. Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc. Natl Acad. Sci. USA 119, e2108870119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR78","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"776_CR79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"776_CR80","doi-asserted-by":"publisher","first-page":"39834","DOI":"10.1074\/jbc.M112.371641","volume":"287","author":"C Wang","year":"2012","unstructured":"Wang, C., Sun, B., Zhou, Y., Grubb, A. & Gan, L. Cathepsin B degrades amyloid-\u03b2 in mice expressing wild-type human amyloid precursor protein. J. Biol. Chem. 287, 39834\u201339841 (2012).","journal-title":"J. Biol. Chem."},{"key":"776_CR81","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/S0002-9440(10)64839-0","volume":"157","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. Astroglial expression of human \u03b11-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am. J. Pathol. 157, 2003\u20132010 (2000).","journal-title":"Am. J. Pathol."},{"key":"776_CR82","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/nbdi.1997.0155","volume":"4","author":"L Dupont-Wallois","year":"1997","unstructured":"Dupont-Wallois, L. et al. ApoE synthesis in human neuroblastoma cells. Neurobiol. Dis. 4, 356\u2013364 (1997).","journal-title":"Neurobiol. Dis."},{"key":"776_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0304-3940(99)00167-6","volume":"265","author":"C Souli\u00e9","year":"1999","unstructured":"Souli\u00e9, C. et al. Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE. Neurosci. Lett. 265, 147\u2013150 (1999).","journal-title":"Neurosci. Lett."},{"key":"776_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/nbdi.2000.0362","volume":"8","author":"RM DeKroon","year":"2001","unstructured":"DeKroon, R. M. & Armati, P. J. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol. Dis. 8, 78\u201389 (2001).","journal-title":"Neurobiol. Dis."},{"key":"776_CR85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."},{"key":"776_CR86","doi-asserted-by":"publisher","first-page":"112994","DOI":"10.1016\/j.celrep.2023.112994","volume":"42","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer\u2019s disease risk gene SORL1. Cell Rep. 42, 112994 (2023).","journal-title":"Cell Rep."},{"key":"776_CR87","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1097\/00005072-199812000-00011","volume":"57","author":"G Einstein","year":"1998","unstructured":"Einstein, G. et al. Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 57, 1190\u20131201 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"776_CR88","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","volume":"154","author":"P-T Xu","year":"1999","unstructured":"Xu, P.-T. et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154, 601\u2013611 (1999).","journal-title":"Am. J. Pathol."},{"key":"776_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(98)00247-X","volume":"246","author":"P-T Xu","year":"1998","unstructured":"Xu, P.-T. et al. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci. Lett. 246, 65\u201368 (1998).","journal-title":"Neurosci. Lett."},{"key":"776_CR90","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky, K. A. et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat. Neurosci. 24, 786\u2013798 (2021).","journal-title":"Nat. Neurosci."},{"key":"776_CR91","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","volume":"28","author":"Q Xu","year":"2008","unstructured":"Xu, Q. et al. Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 28, 1452\u20131459 (2008).","journal-title":"J. Neurosci."},{"key":"776_CR92","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","volume":"10","author":"RW Mahley","year":"1999","unstructured":"Mahley, R. W. & Huang, Y. Apolipoprotein E: from atherosclerosis to Alzheimer\u2019s disease and beyond. Curr. Opin. Lipidol. 10, 207\u2013217 (1999).","journal-title":"Curr. Opin. Lipidol."},{"key":"776_CR93","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1096\/fasebj.10.13.8940294","volume":"10","author":"KH Weisgraber","year":"1996","unstructured":"Weisgraber, K. H. & Mahley, R. W. Human apolipoprotein E: the Alzheimer\u2019s disease connection. FASEB J. 10, 1485\u20131494 (1996).","journal-title":"FASEB J."},{"key":"776_CR94","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li, G. et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5, 634\u2013645 (2009).","journal-title":"Cell Stem Cell"},{"key":"776_CR95","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley, R. W. & Huang, Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76, 871\u2013885 (2012).","journal-title":"Neuron"},{"key":"776_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22262-5","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage. Nat. Commun. 12, 2076 (2021).","journal-title":"Nat. Commun."},{"key":"776_CR97","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1093\/nar\/gkac1107","volume":"50","author":"JA Watts","year":"2022","unstructured":"Watts, J. A. et al. A common transcriptional mechanism involving R-loop and RNA abasic site regulates an enhancer RNA of APOE. Nucleic Acids Res. 50, 12497\u201312514 (2022).","journal-title":"Nucleic Acids Res."},{"key":"776_CR98","doi-asserted-by":"publisher","first-page":"102212","DOI":"10.1016\/j.pneurobio.2021.102212","volume":"209","author":"Z-H Wang","year":"2022","unstructured":"Wang, Z.-H. et al. Neuronal ApoE4 stimulates C\/EBP\u03b2 activation, promoting Alzheimer\u2019s disease pathology in a mouse model. Prog. Neurobiol. 209, 102212 (2022).","journal-title":"Prog. Neurobiol."},{"key":"776_CR99","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini, M. et al. Expression of human apolipoprotein E3 or E4 in the brains of ApoE-\/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867\u20134880 (1999).","journal-title":"J. Neurosci."},{"key":"776_CR100","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/35006165","volume":"404","author":"J Raber","year":"2000","unstructured":"Raber, J. et al. Apolipoprotein E and cognitive performance. Nature 404, 352\u2013354 (2000).","journal-title":"Nature"},{"key":"776_CR101","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","volume":"95","author":"J Raber","year":"1998","unstructured":"Raber, J. et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl Acad. Sci. USA 95, 10914\u201310919 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR102","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.mcpro.2023.100541","volume":"22","author":"Z Cakir","year":"2023","unstructured":"Cakir, Z. et al. Quantitative proteomic analysis reveals apoE4-dependent phosphorylation of the actin-regulating protein VASP. Mol. Cell. Proteom. 22, 100541 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"776_CR103","doi-asserted-by":"publisher","unstructured":"Jang, S.-S. et al. Neuronal apoE4 induces early hyperexcitability in select populations of hippocampal neurons by altering Nell2 expression. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.08.28.555153 (2023).","DOI":"10.1101\/2023.08.28.555153"},{"key":"776_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel, T. et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat. Commun. 8, 1464 (2017).","journal-title":"Nat. Commun."},{"key":"776_CR105","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2016.04.009","volume":"90","author":"AK Gillespie","year":"2016","unstructured":"Gillespie, A. K. et al. Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during hippocampal sharp-wave ripples. Neuron 90, 740\u2013751 (2016).","journal-title":"Neuron"},{"key":"776_CR106","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.celrep.2019.10.056","volume":"29","author":"EA Jones","year":"2019","unstructured":"Jones, E. A., Gillespie, A. K., Yoon, S. Y., Frank, L. M. & Huang, Y. Early hippocampal sharp-wave ripple deficits predict later learning and memory impairments in an Alzheimer\u2019s disease mouse model. Cell Rep. 29, 2123\u20132133.e4 (2019).","journal-title":"Cell Rep."},{"key":"776_CR107","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling, Y. et al. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 30, 13707\u201313717 (2010).","journal-title":"J. Neurosci."},{"key":"776_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053569","volume":"7","author":"L Leung","year":"2012","unstructured":"Leung, L. et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS ONE 7, e53569 (2012).","journal-title":"PLoS ONE"},{"key":"776_CR109","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin, J. et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology 94, e2404\u2013e2411 (2020).","journal-title":"Neurology"},{"key":"776_CR110","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley, R. W., Weisgraber, K. H. & Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 103, 5644\u20135651 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR111","doi-asserted-by":"publisher","first-page":"102684","DOI":"10.1016\/j.conb.2023.102684","volume":"79","author":"RW Mahley","year":"2023","unstructured":"Mahley, R. W. Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer\u2019s disease. Curr. Opin. Neurobiol. 79, 102684 (2023).","journal-title":"Curr. Opin. Neurobiol."},{"key":"776_CR112","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"H-K Chen","year":"2011","unstructured":"Chen, H.-K. et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J. Biol. Chem. 286, 5215\u20135221 (2011).","journal-title":"J. Biol. Chem."},{"key":"776_CR113","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-181184","volume":"68","author":"AL Orr","year":"2019","unstructured":"Orr, A. L. et al. Neuronal apolipoprotein E4 expression results in proteome-wide alterations and compromises bioenergetic capacity by disrupting mitochondrial function. J. Alzheimers Dis. 68, 991\u20131011 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"776_CR114","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2353\/ajpath.2010.090973","volume":"177","author":"M Buttini","year":"2010","unstructured":"Buttini, M. et al. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am. J. Pathol. 177, 563\u2013569 (2010).","journal-title":"Am. J. Pathol."},{"key":"776_CR115","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo, A. M. et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277\u2013286 (2000).","journal-title":"Am. J. Pathol."},{"key":"776_CR116","doi-asserted-by":"publisher","first-page":"21821","DOI":"10.1074\/jbc.M112109200","volume":"277","author":"Z-S Ji","year":"2002","unstructured":"Ji, Z.-S. et al. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 277, 21821\u201321828 (2002).","journal-title":"J. Biol. Chem."},{"key":"776_CR117","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani, A. R., Affaneh, A., Van Gulden, S. & Kessler, J. A. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease. Ann. Neurol. 85, 726\u2013739 (2019).","journal-title":"Ann. Neurol."},{"key":"776_CR118","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1021\/bi8003999","volume":"47","author":"Y Yamauchi","year":"2008","unstructured":"Yamauchi, Y. et al. Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry 47, 6702\u20136710 (2008).","journal-title":"Biochemistry"},{"key":"776_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch, J. N. et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs). Sci. Rep. 8, 6382 (2018).","journal-title":"Sci. Rep."},{"key":"776_CR120","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","volume":"293","author":"BE Stopschinski","year":"2018","unstructured":"Stopschinski, B. E. et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus \u03b1-synuclein and \u03b2-amyloid aggregates. J. Biol. Chem. 293, 10826\u201310840 (2018).","journal-title":"J. Biol. Chem."},{"key":"776_CR121","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. & Diamond, M. I. Prion-like properties of tau protein: the importance of extracellular tau as a therapeutic target. J. Biol. Chem. 289, 19855\u201319861 (2014).","journal-title":"J. Biol. Chem."},{"key":"776_CR122","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez, J. F. et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 25, 1680\u20131683 (2019).","journal-title":"Nat. Med."},{"key":"776_CR123","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-022-02467-8","volume":"144","author":"D Sepulveda-Falla","year":"2022","unstructured":"Sepulveda-Falla, D. et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer\u2019s dementia. Acta Neuropathol. 144, 589\u2013601 (2022).","journal-title":"Acta Neuropathol."},{"key":"776_CR124","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019).","journal-title":"J. Exp. Med."},{"key":"776_CR125","doi-asserted-by":"publisher","unstructured":"Rao, A. et al. Microglia depletion reduces human neuronal APOE4-driven pathologies in a chimeric Alzheimer\u2019s disease model. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.11.10.566510 (2023).","DOI":"10.1101\/2023.11.10.566510"},{"key":"776_CR126","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1073\/pnas.1434398100","volume":"100","author":"FM Harris","year":"2003","unstructured":"Harris, F. M. et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl Acad. Sci. USA 100, 10966\u201310971 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR127","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1073\/pnas.1018381108","volume":"108","author":"N Bien-Ly","year":"2011","unstructured":"Bien-Ly, N. et al. C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice. Proc. Natl Acad. Sci. USA 108, 4236\u20134241 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"776_CR128","doi-asserted-by":"publisher","first-page":"14908","DOI":"10.3390\/ijms140714908","volume":"14","author":"TT Rohn","year":"2013","unstructured":"Rohn, T. T. Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer\u2019s disease. Int. J. Mol. Sci. 14, 14908\u201314922 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"776_CR129","doi-asserted-by":"publisher","first-page":"113252","DOI":"10.1016\/j.celrep.2023.113252","volume":"42","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N. et al. APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release. Cell Rep. 42, 113252 (2023).","journal-title":"Cell Rep."},{"key":"776_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14353-6","volume":"11","author":"H Tanaka","year":"2020","unstructured":"Tanaka, H. et al. YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nat. Commun. 11, 507 (2020).","journal-title":"Nat. Commun."},{"key":"776_CR131","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/jnnp-2017-315869","volume":"89","author":"H Foo","year":"2018","unstructured":"Foo, H. et al. Interaction between APOE-\u025b4 and HMGB1 is associated with widespread cortical thinning in mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry 89, 225\u2013226 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"776_CR132","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.intimp.2016.10.009","volume":"41","author":"Z Wan","year":"2016","unstructured":"Wan, Z. et al. TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I. Int. Immunopharmacol. 41, 74\u201381 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"776_CR133","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1096\/fj.09-144782","volume":"24","author":"C Grundtman","year":"2010","unstructured":"Grundtman, C. et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24, 570\u2013578 (2010).","journal-title":"FASEB J."},{"key":"776_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37437-5","volume":"14","author":"L Brase","year":"2023","unstructured":"Brase, L. et al. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. Nat. Commun. 14, 2314 (2023).","journal-title":"Nat. Commun."},{"key":"776_CR135","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","volume":"186","author":"H Mathys","year":"2023","unstructured":"Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186, 4365\u20134385.e27 (2023).","journal-title":"Cell"},{"key":"776_CR136","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","volume":"132","author":"AA Horvath","year":"2021","unstructured":"Horvath, A. A. et al. Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: a long-term EEG study. Clin. Neurophysiol. 132, 1982\u20131989 (2021).","journal-title":"Clin. Neurophysiol."},{"key":"776_CR137","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel, K. A. et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann. Neurol. 80, 858\u2013870 (2016).","journal-title":"Ann. Neurol."},{"key":"776_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02926-5","volume":"9","author":"M Olah","year":"2018","unstructured":"Olah, M. et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 9, 539 (2018).","journal-title":"Nat. Commun."},{"key":"776_CR139","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-018-0266-4","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju, S. et al. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u2019s disease-related proteins. Mol. Neurodegener. 13, 34 (2018).","journal-title":"Mol. Neurodegener."},{"key":"776_CR140","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"776_CR141","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. 42, 112196 (2023).","journal-title":"Cell Rep."},{"key":"776_CR142","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","volume":"22","author":"A Grubman","year":"2019","unstructured":"Grubman, A. et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 22, 2087\u20132097 (2019).","journal-title":"Nat. Neurosci."},{"key":"776_CR143","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"776_CR144","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142, 3243\u20133264 (2019).","journal-title":"Brain"},{"key":"776_CR145","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.febslet.2013.01.067","volume":"587","author":"LA Voloboueva","year":"2013","unstructured":"Voloboueva, L. A., Emery, J. F., Sun, X. & Giffard, R. G. Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75\/mortalin. FEBS Lett. 587, 756\u2013762 (2013).","journal-title":"FEBS Lett."},{"key":"776_CR146","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"T-PV Huynh","year":"2019","unstructured":"Huynh, T.-P. V. et al. Lack of hepatic apoE does not influence early A\u03b2 deposition: observations from a new APOE knock-in model. Mol. Neurodegener. 14, 37 (2019).","journal-title":"Mol. Neurodegener."},{"key":"776_CR147","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","volume":"29","author":"MB Victor","year":"2022","unstructured":"Victor, M. B. et al. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell 29, 1197\u20131212.e8 (2022).","journal-title":"Cell Stem Cell"},{"key":"776_CR148","doi-asserted-by":"publisher","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","volume":"13","author":"G Sienski","year":"2021","unstructured":"Sienski, G. et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci. Transl. Med. 13, eaaz4564 (2021).","journal-title":"Sci. Transl. Med."},{"key":"776_CR149","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"C-C Liu","year":"2023","unstructured":"Liu, C.-C. et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat. Immunol. 24, 1854\u20131866 (2023).","journal-title":"Nat. Immunol."},{"key":"776_CR150","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol. Neurodegener. 17, 75 (2022).","journal-title":"Mol. Neurodegener."},{"key":"776_CR151","doi-asserted-by":"publisher","first-page":"jcs258687","DOI":"10.1242\/jcs.258687","volume":"135","author":"GM Fote","year":"2022","unstructured":"Fote, G. M. et al. Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins. J. Cell Sci. 135, jcs258687 (2022).","journal-title":"J. Cell Sci."},{"key":"776_CR152","doi-asserted-by":"publisher","first-page":"105615","DOI":"10.1016\/j.nbd.2022.105615","volume":"164","author":"SI Machlovi","year":"2022","unstructured":"Machlovi, S. I. et al. APOE4 confers transcriptomic and functional alterations to primary mouse microglia. Neurobiol. Dis. 164, 105615 (2022).","journal-title":"Neurobiol. Dis."},{"key":"776_CR153","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s004010051002","volume":"97","author":"M Overmyer","year":"1999","unstructured":"Overmyer, M. et al. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol. 97, 383\u2013392 (1999).","journal-title":"Acta Neuropathol."},{"key":"776_CR154","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","volume":"8","author":"R Egensperger","year":"2006","unstructured":"Egensperger, R., K\u00f6sel, S., Eitzen, U. & Graeber, M. B. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol. 8, 439\u2013447 (2006).","journal-title":"Brain Pathol."},{"key":"776_CR155","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek, M. P., Brown, C. M. & Colton, C. A. APOE genotype-specific differences in the innate immune response. Neurobiol. Aging 30, 1350\u20131360 (2009).","journal-title":"Neurobiol. Aging"},{"key":"776_CR156","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fncel.2019.00181","volume":"13","author":"C Muth","year":"2019","unstructured":"Muth, C., Hartmann, A., Sepulveda-Falla, D., Glatzel, M. & Krasemann, S. Phagocytosis of apoptotic cells is specifically upregulated in ApoE4 expressing microglia in vitro. Front. Cell. Neurosci. 13, 181 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"776_CR157","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ajpath.2013.05.009","volume":"183","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease. Am. J. Pathol. 183, 905\u2013917 (2013).","journal-title":"Am. J. Pathol."},{"key":"776_CR158","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"11","author":"Z Yin","year":"2023","unstructured":"Yin, Z. et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat. Immunol. 11, 1839\u20131853 (2023).","journal-title":"Nat. Immunol."},{"key":"776_CR159","doi-asserted-by":"publisher","first-page":"107962","DOI":"10.1016\/j.celrep.2020.107962","volume":"32","author":"R Najm","year":"2020","unstructured":"Najm, R. et al. In vivo chimeric Alzheimer\u2019s disease modeling of apolipoprotein E4 toxicity in human neurons. Cell Rep. 32, 107962 (2020).","journal-title":"Cell Rep."},{"key":"776_CR160","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"10","author":"S-F Lau","year":"2023","unstructured":"Lau, S.-F. et al. The VCAM1\u2013ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat. Aging 10, 1219\u20131236 (2023).","journal-title":"Nat. Aging"},{"key":"776_CR161","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","volume":"111","author":"M Gratuze","year":"2023","unstructured":"Gratuze, M. et al. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Neuron 111, 202\u2013219.e7 (2023).","journal-title":"Neuron"},{"key":"776_CR162","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"776_CR163","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-021-00440-9","volume":"16","author":"K Clayton","year":"2021","unstructured":"Clayton, K. et al. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol. Neurodegener. 16, 18 (2021).","journal-title":"Mol. Neurodegener."},{"key":"776_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp, S. C. et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J. Neuroinflamm. 15, 269 (2018).","journal-title":"J. Neuroinflamm."},{"key":"776_CR165","doi-asserted-by":"publisher","first-page":"eade1474","DOI":"10.1126\/sciadv.ade1474","volume":"9","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza, J. P. et al. APOE \u03b54 associates with microglial activation independently of A\u03b2 plaques and tau tangles. Sci. Adv. 9, eade1474 (2023).","journal-title":"Sci. Adv."},{"key":"776_CR166","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"776_CR167","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s43587-021-00123-6","volume":"1","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A. et al. Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer\u2019s disease. Nat. Aging 1, 919\u2013931 (2021).","journal-title":"Nat. Aging"},{"key":"776_CR168","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"CS Frigerio","year":"2019","unstructured":"Frigerio, C. S. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306.e6 (2019).","journal-title":"Cell Rep."},{"key":"776_CR169","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits, E. et al. Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol. 141, 681\u2013696 (2021).","journal-title":"Acta Neuropathol."},{"key":"776_CR170","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.ajpath.2013.02.031","volume":"182","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo, A., G\u00f3mez-Isla, T., Growdon, J. H., Frosch, M. P. & Hyman, B. T. A phenotypic change but not proliferation underlies glial responses in Alzheimer disease. Am. J. Pathol. 182, 2332\u20132344 (2013).","journal-title":"Am. J. Pathol."},{"key":"776_CR171","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jnr.490330407","volume":"33","author":"LS Perlmutter","year":"1992","unstructured":"Perlmutter, L. S., Scott, S. A., Barr\u00f3n, E. & Chui, H. C. MHC class II-positive microglia in human brain: association with Alzheimer lesions. J. Neurosci. Res. 33, 549\u2013558 (1992).","journal-title":"J. Neurosci. Res."},{"key":"776_CR172","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/cbin.11135","volume":"43","author":"M Chen","year":"2019","unstructured":"Chen, M., Xie, M., Peng, C. & Long, S. The absorption of apolipoprotein E by damaged neurons facilitates neuronal repair. Cell Biol. Int. 43, 623\u2013633 (2019).","journal-title":"Cell Biol. Int."},{"key":"776_CR173","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jnc.15748","volume":"165","author":"KK-S Mok","year":"2023","unstructured":"Mok, K. K.-S. et al. Apolipoprotein E \u03b54 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. J. Neurochem. 165, 55\u201375 (2023).","journal-title":"J. Neurochem."},{"key":"776_CR174","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/glia.23009","volume":"64","author":"D Safina","year":"2016","unstructured":"Safina, D. et al. Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation. Glia 64, 1363\u20131380 (2016).","journal-title":"Glia"},{"key":"776_CR175","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"776_CR176","doi-asserted-by":"publisher","first-page":"14208","DOI":"10.1074\/jbc.M114.625251","volume":"290","author":"CS Casey","year":"2015","unstructured":"Casey, C. S. et al. Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway. J. Biol. Chem. 290, 14208\u201314217 (2015).","journal-title":"J. Biol. Chem."},{"key":"776_CR177","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1523\/JNEUROSCI.4213-04.2005","volume":"25","author":"MMM Wilhelmus","year":"2005","unstructured":"Wilhelmus, M. M. M. et al. Apolipoprotein E genotype regulates amyloid-\u03b2 cytotoxicity. J. Neurosci. 25, 3621\u20133627 (2005).","journal-title":"J. Neurosci."},{"key":"776_CR178","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard, J. W. et al. Reconstruction of the human blood\u2013brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat. Med. 26, 952\u2013963 (2020).","journal-title":"Nat. Med."},{"key":"776_CR179","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.107.3.1207","volume":"107","author":"RA Majack","year":"1988","unstructured":"Majack, R. A. et al. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J. Cell Biol. 107, 1207\u20131213 (1988).","journal-title":"J. Cell Biol."},{"key":"776_CR180","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1161\/ATVBAHA.118.312261","volume":"39","author":"C Rieker","year":"2019","unstructured":"Rieker, C. et al. Apolipoprotein E4 expression causes gain of toxic function in isogenic human induced pluripotent stem cell-derived endothelial cells. Arterioscler. Thromb. Vasc. Biol. 39, e195\u2013e207 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"776_CR181","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainres.2009.12.039","volume":"1315","author":"IB Bruinsma","year":"2010","unstructured":"Bruinsma, I. B. et al. Apolipoprotein E protects cultured pericytes and astrocytes from D-A\u03b21\u201340-mediated cell death. Brain Res. 1315, 169\u2013180 (2010).","journal-title":"Brain Res."},{"key":"776_CR182","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature 603, 885\u2013892 (2022).","journal-title":"Nature"},{"key":"776_CR183","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/ATVBAHA.119.313169","volume":"40","author":"Y Yamazaki","year":"2020","unstructured":"Yamazaki, Y. et al. ApoE in brain pericytes regulates endothelial function in an isoform-dependent manner by modulating basement membrane components. Arterioscler. Thromb. Vasc. Biol. 40, 128\u2013144 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"776_CR184","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday, M. R. et al. Accelerated pericyte degeneration and blood\u2013brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease. J. Cereb. Blood Flow Metab. 36, 216\u2013227 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"776_CR185","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.neuron.2020.11.019","volume":"109","author":"Y Yamazaki","year":"2021","unstructured":"Yamazaki, Y. et al. Vascular apoE4 impairs behavior by modulating glio-vascular function. Neuron 109, 438\u2013447.e6 (2021).","journal-title":"Neuron"},{"key":"776_CR186","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat. Neurosci. 26, 970\u2013982 (2023).","journal-title":"Nat. Neurosci."},{"key":"776_CR187","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12377","volume":"9","author":"LS Honig","year":"2023","unstructured":"Honig, L. S. et al. ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease. Alzheimers Dement. 9, e12377 (2023).","journal-title":"Alzheimers Dement."},{"key":"776_CR188","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway, S. et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 79, 13\u201321 (2022).","journal-title":"JAMA Neurol."},{"key":"776_CR189","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-017-0156-1","volume":"12","author":"JE Pankiewicz","year":"2017","unstructured":"Pankiewicz, J. E. et al. APOE genotype differentially modulates effects of anti-A\u03b2, passive immunization in APP transgenic mice. Mol. Neurodegener. 12, 12 (2017).","journal-title":"Mol. Neurodegener."},{"key":"776_CR190","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y. & Huang, Y. Reducing human apolipoprotein E levels attenuates age-dependent A\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803\u20134811 (2012).","journal-title":"J. Neurosci."},{"key":"776_CR191","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","volume":"31","author":"J Kim","year":"2011","unstructured":"Kim, J. et al. Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-\u03b2 amyloidosis. J. Neurosci. 31, 18007\u201318012 (2011).","journal-title":"J. Neurosci."},{"key":"776_CR192","doi-asserted-by":"publisher","unstructured":"Chemparathy, A. et al. APOE loss-of-function variants: compatible with longevity and associated with resistance to Alzheimer\u2019s disease pathology. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.07.20.23292771 (2023).","DOI":"10.1101\/2023.07.20.23292771"},{"key":"776_CR193","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaneurol.2014.2011","volume":"71","author":"ACY Mak","year":"2014","unstructured":"Mak, A. C. Y. et al. Effects of the absence of apolipoprotein E on lipoproteins, neurocognitive function, and retinal function. JAMA Neurol. 71, 1228\u20131236 (2014).","journal-title":"JAMA Neurol."},{"key":"776_CR194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007791","volume":"14","author":"F Rajabli","year":"2018","unstructured":"Rajabli, F. et al. Ancestral origin of ApoE \u03b54 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 14, e1007791 (2018).","journal-title":"PLoS Genet."},{"key":"776_CR195","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/alz.12287","volume":"17","author":"AJ Griswold","year":"2021","unstructured":"Griswold, A. J. et al. Increased APOE \u03b54 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds. Alzheimers Dement. 17, 1179\u20131188 (2021).","journal-title":"Alzheimers Dement."},{"key":"776_CR196","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"T-PV Huynh","year":"2017","unstructured":"Huynh, T.-P. V. et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron 96, 1013\u20131023.e4 (2017).","journal-title":"Neuron"},{"key":"776_CR197","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim, J. et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J. Exp. Med. 209, 2149\u20132156 (2012).","journal-title":"J. Exp. Med."},{"key":"776_CR198","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk, A. et al. Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model. Ann. Neurol. 89, 952\u2013966 (2021).","journal-title":"Ann. Neurol."},{"key":"776_CR199","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 6, 53 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"776_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10258","volume":"7","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z., Anselmo, A. C. & Mitragotri, S. Viral vector\u2010based gene therapies in the clinic. Bioeng. Transl. Med. 7, e10258 (2021).","journal-title":"Bioeng. Transl. Med."},{"key":"776_CR201","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck, J. et al. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J. Biol. Chem. 286, 17217\u201317226 (2011).","journal-title":"J. Biol. Chem."},{"key":"776_CR202","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"H-K Chen","year":"2012","unstructured":"Chen, H.-K. et al. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J. Biol. Chem. 287, 5253\u20135266 (2012).","journal-title":"J. Biol. Chem."},{"key":"776_CR203","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1523\/JNEUROSCI.0693-14.2014","volume":"34","author":"LM Tong","year":"2014","unstructured":"Tong, L. M. et al. Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with A\u03b2 accumulation. J. Neurosci. 34, 9506\u20139515 (2014).","journal-title":"J. Neurosci."},{"key":"776_CR204","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov, I. et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res. Ther. 11, 113 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"776_CR205","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li, Z., Shue, F., Zhao, N., Shinohara, M. & Bu, G. APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol. Neurodegener. 15, 63 (2020).","journal-title":"Mol. Neurodegener."},{"key":"776_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).","journal-title":"Nat. Commun."},{"key":"776_CR207","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol. Aging 44, 159\u2013172 (2016).","journal-title":"Neurobiol. Aging"},{"key":"776_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13436","author":"C Marino","year":"2023","unstructured":"Marino, C. et al. APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13436 (2023).","journal-title":"Alzheimers Dement."}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41583-023-00776-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-023-00776-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-023-00776-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:30:45Z","timestamp":1706106645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41583-023-00776-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":208,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1038\/s41583-023-00776-9","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"28 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.H. is a co-founder and scientific advisory board member of GABAeron, Inc. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}